Table 3.
Association between adherence and patients’ characteristics by sex (Poisson regression stratified on sex)
| Whole sample (N = 2370) | Women (N = 1227) | Men (N = 1143) | ||
|---|---|---|---|---|
| Bivariate analysis | Multivariate analysis | Bivariate analysis | Multivariate analysis | |
| RR [95% CI] | RR [95% CI] | RR [95% CI] | RR [95% CI] | |
| Age | ||||
| 55; 65 | 1.00 | 1.00 | 1.00 | 1.00 |
| 65; 80 | 1.14 [1.03‐1.26] | 1.15 [1.05‐1.28] | 1.26 [1.1‐1.45] | 1.32 [1.15‐1.5] |
| 80+ | 1.12 [0.99‐1.27] | 1.19 [1.05‐1.35] | 1.27 [1.07‐1.5] | 1.45 [1.23‐1.7] |
| Number of anti‐HTN tablets | ||||
| 1 | 1.00 | 1.00 | 1.00 | 1.00 |
| 2 | 0.97 [0.89‐1.07] | 1.01 [0.92‐1.11] | 0.69 [0.6‐0.79] | 0.74 [0.65‐0.85] |
| 3+ | 0.67 [0.54‐0.84] | 0.72 [0.58‐0.9] | 0.57 [0.45‐0.73] | 0.57 [0.45‐0.72] |
| Number of tablets taken for metabolic diseases | ||||
| 0 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 | 0.91 [0.84‐0.99] | 0.94 [0.86‐1.02] | 0.88 [0.79‐0.99] | 0.92 [0.83‐1.03] |
| 2 | 0.70 [0.58‐0.84] | 0.74 [0.61‐0.88] | 0.61 [0.5‐0.75] | 0.67 [0.55‐0.81] |
| History of cardiovascular diseases | ||||
| No | 1.00 | 1.00 | 1.00 | 1.00 |
| Yes | 0.77 [0.68‐0.88] | 0.80 [0.7‐0.91] | 0.77 [0.68‐0.87] | 0.84 [0.74‐0.96] |
| Number of other chronic diseases | ||||
| 0 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 | 0.94 [0.86‐1.03] | 0.92 [0.85‐1.01] | 0.95 [0.85‐1.06] | 0.94 [0.85‐1.05] |
| 2+ | 0.77 [0.68‐0.87] | 0.78 [0.7‐0.88] | 0.76 [0.63‐0.91] | 0.74 [0.62‐0.88] |
| Contact with health care | ||||
| Low | 1.00 | Not included in the multivariate model | 1.00 | Not included in the multivariate model |
| Intermediate | 0.89 [0.81‐0.98] | 0.97 [0.83‐1.13] | ||
| High | 0.79 [0.70‐ 0.88] | 0.82 [0.7‐0.97] | ||
| Copayment | ||||
| Yes | 1.00 | Not included in the multivariate model | 1.00 | Not included in the multivariate model |
| No | 0.90 [0.83‐0.98] | 0.81 [0.72‐0.91] | ||
Anti‐HTN, antihypertensive.